The STRONG-HF and COACH trials have shown a reduction in morbidity and mortality in patients with acute decompensated heart failure, for whom therapeutical options are currently limited, using two different approaches that have in common the aim of more effective treatment optimization through a better transition phase from in-hospital to outpatient care.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Savarese, G. et al. Heart failure drug treatment-inertia, titration, and discontinuation: a multinational observational study (EVOLUTION HF). JACC Heart Fail. 11, 1–14 (2023).
McDonagh, T. A. et al. 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur. Heart J. 42, 3599–3726 (2021).
Heidenreich, P. A. et al. 2022 AHA/ACC/HFSA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J. Am. Coll. Cardiol. 79, 1757–1780 (2022).
Mebazaa, A. et al. Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): a multinational, open-label, randomised, trial. Lancet 400, 1938–1952 (2022).
Stolfo, D. et al. Use of evidence-based therapy in heart failure with reduced ejection fraction across age strata. Eur. J. Heart Fail. 24, 1047–1062 (2022).
Rosano, G. M. C. et al. Patient profiling in heart failure for tailoring medical therapy. A consensus document of the Heart Failure Association of the European Society of Cardiology. Eur. J. Heart Fail. 23, 872–881 (2021).
Janse, R. J. et al. Use of guideline-recommended medical therapy in patients with heart failure and chronic kidney disease: from physician’s prescriptions to patient’s dispensations, medication adherence and persistence. Eur. J. Heart Fail. 24, 2185–2195 (2022).
Lee, D. S. et al. Trial of an intervention to improve acute heart failure outcomes. N. Engl. J. Med. 388, 22–32 (2023).
Lindberg, F. et al. Patient profile and outcomes associated with follow-up in specialty vs. primary care in heart failure. ESC Heart Fail. 9, 822–833 (2022).
Savarese, G., Lund, L. H., Dahlström, U. & Strömberg, A. Nurse-led heart failure clinics are associated with reduced mortality but not heart failure hospitalization. J. Am. Heart Assoc. 8, e011737 (2019).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Rosano, G.M.C., Savarese, G. Implementing an earlier and more intensive follow-up in acute heart failure: the STRONG-HF and COACH trials. Nat Rev Cardiol 20, 213–214 (2023). https://doi.org/10.1038/s41569-023-00841-x
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41569-023-00841-x